Anastrozole 1 mg Tablets: Medical Uses, Safety and Pharmaceutical Supply in New York, USA
Anastrozole 1 mg is a prescription medicine used primarily in the treatment of certain hormone receptor-positive breast cancers in postmenopausal women. It is a member of a group of medications called aromatase inhibitors, which lower the body's production of oestrogen. For healthcare institutions, licensed pharmaceutical distributors and procurement professionals in New York, understanding the medicine's clinical applications, quality documentation and regulatory requirements is essential.
Primecare Impex, an India-based pharmaceutical export business, provides pharmaceutical sourcing and international procurement support. This guide explains the medical role of Anastrozole, important safety considerations and factors relevant to its international supply.
1. What Is Anastrozole 1 mg?
Anastrozole is a nonsteroidal aromatase inhibitor used in hormone-dependent breast cancer treatment. It works by inhibiting the aromatase enzyme, which converts certain hormones into estrogen. Reducing estrogen levels can help slow the growth of breast cancer cells that depend on estrogen.
Product overview
Product Details | Information |
|---|---|
Brand shown | ANA-ASH 1 |
Generic name | Anastrozole |
Strength | 1 mg |
Dosage form | Oral tablet |
Medicine category | Aromatase inhibitor |
Therapeutic category | Oncology |
Administration | Oral |
Prescription status | Prescription medicine |
The supplied product image shows ANA-ASH 1 Anastrozole Tablets 1 mg in a carton marked 10 × 10 tablets. Actual packaging and availability should be confirmed before procurement.
2. Medical Uses of Anastrozole 1 mg
Anastrozole is prescribed for specific breast cancer indications in postmenopausal women.
Early-stage hormone receptor-positive breast cancer
Anastrozole may be prescribed as adjuvant endocrine treatment following primary treatment for hormone receptor-positive early breast cancer. Its purpose is to reduce estrogen activity and lower the risk of cancer recurrence.
Advanced breast cancer
Anastrozole may be used as first-line treatment for certain hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancers in postmenopausal women.
Breast cancer progression after tamoxifen
It may also be prescribed for advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen treatment, subject to the relevant clinical indication.
3. How Does Anastrozole Work?
Estrogen can stimulate the growth of certain breast cancer cells.
In postmenopausal women, much of the body's estrogen is produced through the conversion of androgens into estrogen by the aromatase enzyme. Anastrozole blocks this enzyme, lowering circulating estrogen levels. This mechanism makes it useful in the treatment of estrogen-sensitive breast cancer. Anastrozole is not a chemotherapy medicine. It is a form of endocrine therapy.
4. Recommended Dosage and Administration
The commonly recommended adult dose for its approved breast cancer indications is:
Anastrozole 1 mg orally once daily.
The tablet may generally be taken with or without food. Treatment duration depends on the indication, disease stage, response and treating oncologist's recommendations. Patients should not change the prescribed dose or discontinue treatment without consulting their healthcare professional.
5. Possible Side Effects of Anastrozole
Like other prescription medicines, Anastrozole may cause adverse effects.
Commonly reported effects include:
Hot flashes
Joint pain or stiffness
Headache
Fatigue
Nausea
Weakness
Bone or muscle pain
Important safety considerations
Anastrozole may reduce bone mineral density, potentially increasing the risk of osteoporosis and fractures.
It may also affect cholesterol levels. Cardiovascular risk should be considered in patients with pre-existing ischemic heart disease.
Healthcare professionals may recommend bone health assessment and other monitoring according to the patient's individual risk profile.
Seek urgent medical attention for symptoms suggesting a severe allergic reaction or serious cardiovascular event.
6. Precautions Before Using Anastrozole
Patients should inform their healthcare provider about their medical history and current medicines.
Important considerations include:
Pregnancy: Anastrozole can cause fetal harm and should not be used during pregnancy.
Breastfeeding: Breastfeeding is not recommended during treatment and for the period specified in the applicable prescribing information.
Bone health: Patients with osteoporosis or increased fracture risk may require additional monitoring.
Drug interactions: Estrogen-containing therapies and tamoxifen may interfere with Anastrozole treatment and should not be combined without appropriate medical direction.
Menopausal status: The medicine's approved indications and suitability depend on the patient's menopausal status and clinical circumstances.
7. Anastrozole 1 mg Pharmaceutical Supply in New York, USA
New York's healthcare procurement network includes hospitals, oncology treatment centers, licensed wholesalers and specialty pharmacies. These organizations require reliable medicine sourcing, product traceability and appropriate regulatory documentation.
Primecare Impex supports pharmaceutical sourcing discussions for international buyers seeking information about medicines manufactured in India.
Product quality documentation
Depending on the product and manufacturer, relevant documentation may include:
Certificate of Analysis (COA)
Batch number and manufacturing details
Expiry date and remaining shelf life
Manufacturer information
Applicable manufacturing quality documentation
Product-specific regulatory documentation
Documentation availability must be confirmed for the actual product and batch.
Packaging and shipment planning
Pharmaceutical procurement requires appropriate packaging, traceability and storage arrangements.
Buyers should verify product labeling, batch information, transport requirements and destination-country import rules before shipment.
US regulatory compliance
Medicines imported into the United States must meet applicable FDA and Customs and Border Protection requirements. A product being manufactured or marketed in India does not automatically mean that it can legally be imported, distributed or sold in the United States. US buyers should verify the product's FDA approval status, labeling, manufacturer eligibility, importer responsibilities and applicable distribution requirements.
8. Why Pharmaceutical Buyers Evaluate Indian Medicine Suppliers
India is an important source of pharmaceutical manufacturing and international medicine procurement.
For licensed buyers, supplier selection should involve more than a price comparison.
Important evaluation criteria include manufacturing quality, batch traceability, documentation, product registration, packaging standards and reliable communication.
Primecare Impex can serve as a point of contact for product sourcing inquiries and documentation discussions.
Any proposed supply of Anastrozole to New York must be assessed against applicable US regulatory requirements before an order is confirmed.
9. Storage and Handling
Anastrozole tablets should be stored according to the manufacturer's approved product labeling.For many Anastrozole 1 mg tablet products, controlled room-temperature storage is specified, but the requirements for the actual brand and batch should be verified.Keep tablets in their original packaging, protect them from unsuitable storage conditions and keep them out of children's reach.
Pharmaceutical distributors should follow applicable storage and distribution requirements throughout the supply chain.
